The Institute for Clinical and Economic Review is seeking new members for the New England Comparative Effectiveness Public Advisory Council, in addition to two other councils in California and the Midwest. Many health policy experts blame new technologies for drugs, devices and other innovations with driving health costs up without necessarily improving the quality of care. The Councils include leading clinician, patient and public representatives, researchers, and health economists who meet a few times a year to consider, and vote on, the effectiveness and value of new health treatments. Previous topics include treatments for liver disease, multiple myeloma, and lung cancer, as well as system-level interventions such as palliative care and diabetes prevention programs. Members must meet conflict of interest guidelines and will be reimbursed for travel to meetings and for their time. To apply, send a CV/resume and letter of interest to email@example.com by December 15th. Learn more about ICER here, here and here.